✦ LIBER ✦

Intermittent combined chemotherapy with doxorubicin in recurrent childhood acute lymphoblastic leukemia

✍ Scribed by Platt, M. P. Ward ;Mott, M. G. ;Eden, O. B.

Publisher: John Wiley and Sons
Year: 1982
Tongue: English
Weight: 298 KB
Volume: 10
Category: Article
ISSN: 0098-1532
DOI: 10.1002/mpo.2950100606

No coin nor oath required. For personal study only.

✦ Synopsis

Abstract

A series of 14 children with bone marrow or testicular recurrence of acute lymphoblastic leukemia (ALL) and treated with pulsed combined chemotherapy incorporating doxorubicin is reviewed. All had been previously adequately treated according to established leukemia protocols. Median disease‐free survival for the series is 46 weeks, overall survival 62 weeks, and the toxicity of the therapy relatively low. This compares favorably with other reports of treatment of relapsed ALL and supports the formulation of prospective trials to evaluate anthracyclines in initial induction and consolidation phases of treatment of childhood ALL.

📜 SIMILAR VOLUMES

6-azauridine in combination chemotherapy

6-azauridine in combination chemotherapy of childhood acute myelocytic leukemia

✍ T. R. Walters; R. J. A. Aur; K. Hernandez; T. Vietti; D. Pinkel 📂 Article 📅 1972 🏛 John Wiley and Sons 🌐 English ⚖ 314 KB 👁 2 views

Chemotherapy with cyclophosphamide, vinc

Chemotherapy with cyclophosphamide, vincristine, cytosine arabinoside, and prednisone (COAP) in childhood acute lymphoblastic leukemia (ALL)

✍ Sallan, Stephen E. ;Camitta, Bruce M. ;Chan, David M. ;Traggis, Demitrius ;Jaffe 📂 Article 📅 1977 🏛 John Wiley and Sons 🌐 English ⚖ 290 KB

## Abstract Three groups of children with acute lymphoblastic leukemia (ALL) were treated with intermittent cyclophosphamide, vincristine, cytosine arabinoside, and prednisone (COAP). Group A (no prior relapse) and Group B (prior single‐agent relapse) received COAP after 12 months on another chemot

Recurrent mercaptopurine-induced acute p

Recurrent mercaptopurine-induced acute pancreatitis: A rare complication of chemotherapy for acute lymphoblastic leukemia in children

✍ Willert, Jennifer Reikes ;Dahl, Gary V. ;Marina, Neyssa M. 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 37 KB

Oral outpatient chemotherapy medication

Oral outpatient chemotherapy medication errors in children with acute lymphoblastic leukemia

✍ James A. Taylor; Laura Winter; Leah J. Geyer; Douglas S. Hawkins 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 126 KB

Neuromuscular impairments in adult survi

Neuromuscular impairments in adult survivors of childhood acute lymphoblastic leukemia : Associations with physical performance and chemotherapy doses

✍ Kirsten K. Ness; Melissa M. Hudson; Ching-Hon Pui; Daniel M. Green; Kevin R. Kru 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 181 KB 👁 1 views

Adriamycin in combination chemotherapy o

Adriamycin in combination chemotherapy of adult acute lymphoblastic leukemia: A southwest oncology group study

✍ Shaw, Michael T. ;Raab, Spencer O. 📂 Article 📅 1977 🏛 John Wiley and Sons 🌐 English ⚖ 350 KB

## Abstract Eighteen (72%) of 25 evaluable and previously untreated patients with adult acute lymphoblastic leukemia entered complete remission (CR) following induction therapy with Adriamycin, vincristine, and prednisone in a Southwest Oncology Group study. Remission maintenance therapy with metho